Associate Professor Carolyn Day

Associate Professor
Addiction Medicine, Central Clinical School

Telephone +61 2 9515 8817

Map

Research interests

I am interested in all areas of drug and alcohol and addiction medicine, but have extensive experience in the area of injecting and illicit drug use and blood-borne infection. Key interest /areas of expertise include: Injecting drug use; hepatitis C epidemiology, prevention and treatment; hepatitis B vaccination; illicit drug use epidemiology and markets; treatments for opioid dependence.

Teaching and supervision

I have coordinated addiction medicine education in the Sydney Medical Program since 2007 and coorindate the unit of study "Alcohol, Drug and Health" (PUBH5114/5).

Selected grants

2011

  • Factors influencing pharmacy services in opiod substitution programs; Day C, Chaar B, Fois R, Hanrahan J; Health Administration Corporation/Research Support.
  • Unmet healthcare needs and barriers to healthcare utilisation of young Aboriginal drug users in inner city Sydney: a pilot study; Conigrave K, Day C; Health Administration Corporation/Drug and Alcohol Research Grant.

2010

  • LNK transfer: NHMRC partnership project 'Evaluation of a Model for Assessment and Treatment of Hepat; Day C, Miszczak E, Hirshorn J.

2007

  • The impact of injecting patterns and drug dependence treatment on hepatitis C treatment outcomes for injecting drug users; Day C; National Health and Medical Research Council (NHMRC)/Early Career Fellowships (ECF).

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Day, C., Haber, P. (2009). Managing drug dependence in people with hepatitis C. In G. Dore, M. Temple-Smith, A. Lloyd (Eds.), Hepatitis C: An Expanding Perspective, (pp. 288-307). East Hawthorn, Victoria: IP Communications.

Journals

  • Deacon, R., Hines, S., Curry, K., Tynan, M., Day, C. (2014). Feasibility of ambulatory withdrawal management delivered in a NSW drug health service and correlates of completion. Australian Health Review, 38(2), 186-189. [More Information]
  • Islam, M., Conigrave, K., Day, C., Nguyen, Y., Haber, P. (2014). Twenty-year trends in benzodiazepine dispensing in the Australian population. Internal Medicine Journal, 44(1), 57-64. [More Information]
  • Topp, L., Day, C., Wand, H., Deacon, R., Van Beek, I., Haber, P., Shanahan, M., Rodgers, C., Maher, L. (2013). A randomised controlled trial of �?nancial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia. Preventive Medicine, 57(4), 297-303. [More Information]
  • Islam, M., Topp, L., Conigrave, K., White, A., Haber, P., Day, C. (2013). Are primary health care centres that target injecting drug users attracting and serving the clients they are designed for? A case study from Sydney, Australia. International Journal of Drug Policy, 24(4), 326-332. [More Information]
  • Alavi, M., Grebely, J., Micallef, M., Dunlop, A., Balcomb, A., Day, C., Treloar, C., Bath, N., Haber, P., Dore, G. (2013). Assessment and Treatment of Hepatitis C Virus Infection Among People Who Inject Drugs in the Opioid Substitution Setting: ETHOS Study. Clinical Infectious Diseases, 57(Suppl 2), S62-S69. [More Information]
  • Md Mofizul, M., Topp, L., Conigrave, K., Day, C. (2013). De�?ning a service for people who use drugs as 'low-threshold': What should be the criteria? International Journal of Drug Policy, 24(3), 220-222. [More Information]
  • Chaar, B., Wang, H., Day, C., Hanrahan, J., Winstock, A., Fois, R. (2013). Factors influencing pharmacy services in opioid substitution treatment. Drug and Alcohol Review, 32(4), 426-434. [More Information]
  • Islam, M., Taylor, A., Smyth, C., Day, C. (2013). General health of opioid substitution therapy clients. Internal Medicine Journal, 43(12), 1335-1338. [More Information]
  • Islam, M., Topp, L., Iversen, J., Day, C., Conigrave, K., Maher, L. (2013). Healthcare utilisation and disclosure of injecting drug use among clients of Australia's needle and syringe programs. Australian and New Zealand Journal of Public Health, 37(2), 148-154. [More Information]
  • Islam, M., Topp, L., Conigrave, K., Day, C. (2013). Opioid substitution therapy clients' preferences for targeted versus general primary health-care outlets. Drug and Alcohol Review, 32(2), 211-214. [More Information]
  • Topp, L., Islam, M., Day, C. (2013). Relative efficacy of cash versus vouchers in engaging opioid substitution treatment clients in survey-based research. Journal of Medical Ethics, 39(4), 253-256. [More Information]
  • Mofizul Islam, M., Day, C., Conigrave, K., Topp, L. (2013). Self-perceived problem with alcohol use among opioid substitution treatment clients. Addictive Behaviors, 38(4), 2018-2021. [More Information]
  • Islam, M., Topp, L., Conigrave, K., Haber, P., White, A., Day, C. (2013). Sexually transmitted infections, sexual risk behaviours and perceived barriers to safe sex among drug users. Australian and New Zealand Journal of Public Health, 37(4), 311-315. [More Information]
  • Islam, M., Shanahan, M., Topp, L., Conigrave, K., White, A., Day, C. (2013). The cost of providing primary health-care services from a needle and syringe program: A case study. Drug and Alcohol Review, 32(3), 312-319. [More Information]
  • Deacon, R., Topp, L., Wand, H., Day, C., Rodgers, C., Haber, P., van Beek, I., Maher, L. (2012). Correlates of Susceptibility to Hepatitis B among People Who Inject Drugs in Sydney, Australia. Journal of Urban Health, 89(5), 769-778. [More Information]
  • Alavi, M., Grebely, J., Matthews, G., Petoumenos, K., Yeung, B., Day, C., Lloyd, A., van Beek, I., Kaldor, J., Hellard, M., Haber, P., et al (2012). Effect of pegylated interferon alfa-2a treatment on mental health during recent hepatitis C virus infection. Journal of Gastroenterology and Hepatology, 27(5), 957-965. [More Information]
  • Day, C., Demirkol, A., Tynan, M., Curry, K., Hines, S., Lintzeris, N., Haber, P. (2012). Individual versus team-based case-management for clients of opioid treatment services: An initial evaluation of what clients prefer. Drug and Alcohol Review, 31(4), 499-506. [More Information]
  • Islam, M., Topp, L., Conigrave, K., White, A., Reid, S., Grummett, S., Haber, P., Day, C. (2012). Linkage into specialist hepatitis C treatment services of injecting drug users attending a needle syringe program-based primary healthcare centre. Journal of Substance Abuse Treatment, 43(4), 440-445. [More Information]
  • Mofizul Islam, M., Topp, L., Day, C., Dawson, A., Conigrave, K. (2012). Primary healthcare outlets that target injecting drug users: Opportunity to make services accessible and acceptable to the target group. International Journal of Drug Policy, 23(2), 109-110. [More Information]
  • Mofizul Islam, M., Topp, L., Day, C., Dawson, A., Conigrave, K. (2012). The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: A narrative synthesis of literature. International Journal of Drug Policy, 23(2), 94-102. [More Information]
  • Islam, M., Topp, L., Conigrave, K., van Beek, I., Maher, L., White, A., Rodgers, C., Day, C. (2012). The reliability of sensitive information provided by injecting drug users in a clinical setting: Clinician-administered versus audio computer-assisted self-interviewing (ACASI). AIDS Care - Psychological and Socio-Medical Aspects of AIDS/Hiv, 24(12), 1496-1503. [More Information]
  • Mofizul Islam, M., Grummett, S., White, A., Reid, S., Day, C., Haber, P. (2011). A primary healthcare clinic in a needle syringe program may contribute to HIV prevention by early detection of incident HIV in an injecting drug user. Australian and New Zealand Journal of Public Health, 35(3), 294-295. [More Information]
  • Day, C., Topp, L. (2011). Commentary on Turner et al. (2011): Significant global scale-up of harm reduction interventions and pragmatic research approaches needed to prevent hepatitis C transmission. Addiction, 106(11), 1989-1990. [More Information]
  • Day, C., Mofizul Islam, M., White, A., Reid, S., Hayes, S., Haber, P. (2011). Development of a nurse-led primary healthcare service for injecting drug users in inner-city Sydney. Australian Journal of Primary Health, 17(1), 10-15. [More Information]
  • Topp, L., Day, C., Iversen, J., Wand, H., Maher, L. (2011). Fifteen years of HIV surveillance among people who inject drugs: the Australian Needle and Syringe Program Survey 1995–2009. AIDS, 25(6), 835-842. [More Information]
  • Chaar, B., Hanrahan, J., Day, C. (2011). Provision of Opioid Substitution Therapy Services in Australian Pharmacies. The Australasian Medical Journal, 4(4), 210-216. [More Information]
  • Sanson-Fisher, R., Brand, M., Shakeshaft, A., Haber, P., Day, C., Conigrave, K., Mattick, R., Lintzeris, N., Teesson, M. (2010). Forming a national multicentre collaboration to conduct clinical trials: increasing high-quality research in the drug and alcohol field. Drug and Alcohol Review, 29(5), 469-474. [More Information]
  • Mofizul Islam, M., Day, C., Conigrave, K. (2010). Harm reduction healthcare: From an alternative to the mainstream platform? International Journal of Drug Policy, 21(2), 131-133. [More Information]
  • Day, C., White, B., Dore, G., van Beek, I., Rodgers, C., Cunningham, P., Wodak, A., Maher, L. (2010). Hepatitis B virus among injecting drug users in Sydney, Australia: prevalence, vaccination and knowledge of status. Drug and Alcohol Dependence, 108(40210 (1-2)), 134-137. [More Information]
  • Dunn, M., Day, C., Bruno, R., Degenhardt, L., Campbell, G. (2010). Sexual and injecting risk behaviours among regular ecstasy users. Addictive Behaviors, 35(2), 157-160. [More Information]
  • Ramasamy, P., Lintzeris, N., Sutton, Y., Taylor, H., Day, C., Haber, P. (2010). The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinic. Addiction, 105(2), 329-334. [More Information]
  • Doab, A., Topp, L., Day, C., Dore, G., Maher, L. (2009). Clinical trial literacy among injecting drug users in Sydney, Australia: A pilot study. Contemporary Clinical Trials, 30(5), 431-435. [More Information]
  • Topp, L., Day, C., Dore, G., Maher, L. (2009). Poor criterion validity of self-reported hepatitis B infection and vaccination status among injecting drug users: A review. Drug and Alcohol Review, 28(6), 669-675. [More Information]
  • Coupland, H., Day, C., Levy, M., Maher, L. (2009). Promoting equitable access to hepatitis C treatment for Indo-Chinese injecting drug users. Health Promotion Journal of Australia, 20(3), 234-240. [More Information]
  • White, B., Day, C., Thein, H., Doab, A., Bates, A., Holden, J., van Beek, I., Maher, L. (2008). Acceptability of hepatitis C virus testing methods among injecting drug users. Drug and Alcohol Review, 27, 666-670. [More Information]
  • Conroy, E., Kimber, J., Dolan, K., Day, C. (2008). An examination of the quality of life among rural and outer metropolitan injecting drug users in NSW, Australia. Addiction Research and Theory, 16(6), 607-617. [More Information]
  • Conroy, E., Kimber, J., Dolan, K., Day, C. (2008). An examination of the quality of life among rural and outer metropolitan injecting drug users in NSW, Australia. Addiction Research and Theory, 16, 607-617. [More Information]
  • Day, C., Topp, L., Iversen, J., Maher, L., Australian NSPs, C. (2008). Blood-borne virus prevalence and risk among steroid injectors: Results from the Australian Needle and Syringe Program Survey. Drug and Alcohol Review, 27(5), 559-561. [More Information]
  • Day, C., White, B., Thein, H., Doab, A., Dore, G., Bates, A., Holden, J., Maher, L. (2008). Experience of hepatitis C testing among injecting drug users in Sydney, Australia. AIDS Care - Psychological and Socio-Medical Aspects of AIDS/Hiv, 20(1), 116-123. [More Information]
  • O'Brien, S., Day, C., Black, E., Dolan, K. (2008). Injecting drug users' understanding of hepatitis C. Addictive Behaviors, 33(12), 1602-1605. [More Information]
  • Topp, L., Iversen, J., Wand, H., Day, C., Kaldor, J., Maher, L. (2008). Representativeness of Injecting Drug Users Who Participate in HIV Surveillance: Results From Australia’s Needle and Syringe Program Survey. JAIDS-Journal of Acquired Immune Deficiency Syndromes, 47(5), 632-638. [More Information]
  • White, B., Day, C., Maher, L. (2007). Self reported risk behaviour among injecting drug users: Self versus assisted questionnaire completion. AIDS Care - Psychological and Socio-Medical Aspects of AIDS/Hiv, 19(3), 441-447. [More Information]
  • Day, C., Degenhardt, L., Hall, W. (2006). Changes in the initiation of heroin use after a reduction in heroin supply. Drug and Alcohol Review, 25(4), 307-313. [More Information]
  • Day, C., Dolan, K. (2006). Correlates of hepatitis C testing among heroin injectors in Sydney. Health Promotion Journal of Australia, 17(1), 70-72. [More Information]
  • Day, C., Degenhardt, L., Hall, W. (2006). Documenting the heroin shortage in New South Wales. Drug and Alcohol Review, 25(4), 297-305. [More Information]
  • Degenhardt, L., Day, C., Conroy, E., Gilmour, S. (2006). Examining Links Between Cocaine Use and Street-Based Sex Work in New South Wales, Australia. Journal of Sex Research, 43(2), 107-114. [More Information]
  • Gilmour, S., Koch, I., Degenhardt, L., Day, C. (2006). Identification and quantification of change in Australian illicit drug markets. BMC Public Health, 6, 200-1-200-10. [More Information]
  • Conroy, E., Degenhardt, L., Day, C. (2006). Impact of Drug Market Changes on Substance-Using Pregnant Women in Three Key Sydney Drug Markets. Women and Health: the multidisciplinary journal of women's health issues, 44(4), 93-105. [More Information]
  • Day, C., Nassirimanesh, B., Shakeshaft, A., Dolan, K. (2006). Patterns of drug use among a sample of drug users and injecting drug users attending a General Practice in Iran. Harm Reduction Journal, 3, 2-1-2-5. [More Information]
  • Day, C., Conroy, E., Lowe, J., Page, J., Dolan, K. (2006). Patterns of drug use and associated harms among rural injecting drug users: Comparisons with metropolitan injecting drug users. Australian Journal of Rural Health, 14(3), 120-125. [More Information]
  • White, B., Day, C., Degenhardt, L., Kinner, S., Fry, C., Bruno, R., Johnston, J. (2006). Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia. Drug and Alcohol Dependence, 83(3), 210-217. [More Information]
  • Degenhardt, L., Day, C., Gilmour, S., Hall, W. (2006). The "lessons" of the Australian "heroin shortage". Substance Abuse Treatment, Prevention, and Policy, 1, 11-1-11-7. [More Information]
  • Gilmour, S., Degenhardt, L., Hall, W., Day, C. (2006). Using intervention time series analyses to assess the effects of imperfectly identifiable natural events: a general method and example. BMC Medical Research Methodology, 6, 16-1-16-9. [More Information]
  • Degenhardt, L., Day, C., Conroy, E., Gilmour, S., Hall, W. (2005). Age differentials in the impacts of reduced heroin: Effects of a "heroin shortage" in NSW, Australia. Drug and Alcohol Dependence, 79(3), 397-404. [More Information]
  • Degenhardt, L., Day, C., Dietze, P., Pointer, S., Conroy, E., Collins, L., Hall, W. (2005). Effects of a sustained heroin shortage in three Australian States. Addiction, 100(7), 908-920. [More Information]
  • Day, C., Ross, J., Dietze, P., Dolan, K. (2005). Initiation to heroin injecting among heroin users in Sydney, Australia: cross sectional survey. Harm Reduction Journal, 2, 2-1-2-7. [More Information]
  • Degenhardt, L., Hall, W., Day, C., Dietze, P., Collins, L., Pointer, S. (2005). Mapping the Consequences of an Unanticipated Drug Supply Change of Uncertain Origins: Response to the Commentaries. Addiction, 100(7), 930-932. [More Information]
  • Degenhardt, L., Day, C., Gilmour, S., Hall, W. (2005). Patterns of illicit drug use in NSW, Australia following a reduction in heroin supply. International Journal of Drug Policy, 16(5), 300-307. [More Information]
  • Shakeshaft, A., Nassirimanesh, B., Day, C., Dolan, K. (2005). Perceptions of substance use, treatment options and training needs among Iranian primary care physicians. International Journal for Equity in Health, 4, 7-1-7-6. [More Information]
  • Gibson, A., Degenhardt, L., Day, C., McKetin, R. (2005). Recent trends in heroin supply to markets in Australia, the United States and Western Europe. International Journal of Drug Policy, 16(5), 293-299. [More Information]
  • Degenhardt, L., Conroy, E., Day, C., Gilmour, S., Hall, W. (2005). The impact of a reduction in drug supply on demand for and compliance with treatment for drug dependence. Drug and Alcohol Dependence, 79(2), 129-135. [More Information]
  • Day, C., Degenhardt, L., Gilmour, S., Hall, W. (2005). The impact of changes to heroin supply on blood-borne virus notifications and injecting related harms in New South Wales, Australia. BMC Public Health, 5, 84-1-84-8. [More Information]
  • Gibson, A., Day, C., Degenhardt, L. (2005). The impact of illicit drug market changes on health agency operations in Sydney, Australia. Journal of Substance Abuse Treatment, 28(1), 35-40. [More Information]
  • Degenhardt, L., Day, C., Hall, W., Conroy, E., Gilmour, S. (2005). Was an increase in cocaine use among injecting drug users in New South Wales, Australia, accompanied by an increase in violent crime? BMC Public Health, 5, 40-1-40-10. [More Information]
  • Southgate, E., Weatherall, A., Day, C., Dolan, K. (2005). What's in a virus? Folk understandings of hepatitis C infection and infectiousness among injecting drug users in Kings Cross, Sydney. International Journal for Equity in Health, 4, 5-1-5-6. [More Information]
  • Day, C., Degenhardt, L., Gilmour, S., Hall, W. (2004). Effects of reduction in heroin supply on injecting drug use: analysis of data from needle and syringe programmes. BMJ: British Medical Journal, 329(7463), 428-429. [More Information]
  • Day, C., Jayasuriya, R., Stone, G. (2004). Hepatitis C-related discriminationin New South Wales. Australian Health Review, 27(2), 57-60.
  • Day, C., Collins, L., Degenhardt, L., Thetford, C., Maher, L. (2004). Reliability of Heroin Users' Reports of Drug Use Behaviour Using a 24-Month Timeline-Follow-Back Technique to Assess the Impact of the Australian Heroin Shortage. Addiction Research and Theory, 12(5), 433-443. [More Information]
  • Lynskey, M., Day, C., Hall, W. (2003). Alcohol and other drug use disorders among older-aged people. Drug and Alcohol Review, 22(2), 125-133.
  • Topp, L., Day, C., Degenhardt, L. (2003). Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia. Drug and Alcohol Dependence, 70, 275-286. [More Information]
  • Day, C., Ross, J., Dolan, K. (2003). Characteristics of Aboriginal Injecting Drug Users in Sydney, Australia: Prison History, Hepatitis C Status and Drug Treatment Experiences. Journal of Ethnicity in Substance Abuse, 2(3), 51-58. [More Information]
  • Topp, L., Degenhardt, L., Day, C., Collins, L. (2003). Contemplating drug monitoring systems in the light of Australia's "heroin shortage" [Editorial]. Drug and Alcohol Review, 22(1), 3-6. [More Information]
  • Day, C., Topp, L., Rouen, D., Darke, S., Hall, W., Dolan, K. (2003). Decreased heroin availability in Sydney in early 2001. Addiction, 98(1), 93-95. [More Information]
  • Day, C., Ross, J., Dolan, K. (2003). Hepatitis C-related discrimination among heroin users in Sydney: drug user or hepatitis C discrimination? Drug and Alcohol Review, 22(3), 317-321. [More Information]
  • Degenhardt, L., Topp, L., Day, C. (2003). Issues surrounding the detection of a reduction in drug supply: the heroin shortage in Australia in 2001. United Nations. Bulletin on Narcotics, 55(1-2), 131-140.
  • Day, C., White, B., Ross, J., Dolan, K. (2003). Poor knowledge and low coverage of hepatitis B vaccination among injecting drug users in Sydney [Letter]. Australian and New Zealand Journal of Public Health, 27(5), 558.
  • Day, C., Topp, L. (2003). Safety in drug and alcohol research [Editorial]. Addiction, 98(12), 1641-1643. [More Information]

2014

  • Deacon, R., Hines, S., Curry, K., Tynan, M., Day, C. (2014). Feasibility of ambulatory withdrawal management delivered in a NSW drug health service and correlates of completion. Australian Health Review, 38(2), 186-189. [More Information]
  • Islam, M., Conigrave, K., Day, C., Nguyen, Y., Haber, P. (2014). Twenty-year trends in benzodiazepine dispensing in the Australian population. Internal Medicine Journal, 44(1), 57-64. [More Information]

2013

  • Topp, L., Day, C., Wand, H., Deacon, R., Van Beek, I., Haber, P., Shanahan, M., Rodgers, C., Maher, L. (2013). A randomised controlled trial of �?nancial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia. Preventive Medicine, 57(4), 297-303. [More Information]
  • Islam, M., Topp, L., Conigrave, K., White, A., Haber, P., Day, C. (2013). Are primary health care centres that target injecting drug users attracting and serving the clients they are designed for? A case study from Sydney, Australia. International Journal of Drug Policy, 24(4), 326-332. [More Information]
  • Alavi, M., Grebely, J., Micallef, M., Dunlop, A., Balcomb, A., Day, C., Treloar, C., Bath, N., Haber, P., Dore, G. (2013). Assessment and Treatment of Hepatitis C Virus Infection Among People Who Inject Drugs in the Opioid Substitution Setting: ETHOS Study. Clinical Infectious Diseases, 57(Suppl 2), S62-S69. [More Information]
  • Md Mofizul, M., Topp, L., Conigrave, K., Day, C. (2013). De�?ning a service for people who use drugs as 'low-threshold': What should be the criteria? International Journal of Drug Policy, 24(3), 220-222. [More Information]
  • Chaar, B., Wang, H., Day, C., Hanrahan, J., Winstock, A., Fois, R. (2013). Factors influencing pharmacy services in opioid substitution treatment. Drug and Alcohol Review, 32(4), 426-434. [More Information]
  • Islam, M., Taylor, A., Smyth, C., Day, C. (2013). General health of opioid substitution therapy clients. Internal Medicine Journal, 43(12), 1335-1338. [More Information]
  • Islam, M., Topp, L., Iversen, J., Day, C., Conigrave, K., Maher, L. (2013). Healthcare utilisation and disclosure of injecting drug use among clients of Australia's needle and syringe programs. Australian and New Zealand Journal of Public Health, 37(2), 148-154. [More Information]
  • Islam, M., Topp, L., Conigrave, K., Day, C. (2013). Opioid substitution therapy clients' preferences for targeted versus general primary health-care outlets. Drug and Alcohol Review, 32(2), 211-214. [More Information]
  • Topp, L., Islam, M., Day, C. (2013). Relative efficacy of cash versus vouchers in engaging opioid substitution treatment clients in survey-based research. Journal of Medical Ethics, 39(4), 253-256. [More Information]
  • Mofizul Islam, M., Day, C., Conigrave, K., Topp, L. (2013). Self-perceived problem with alcohol use among opioid substitution treatment clients. Addictive Behaviors, 38(4), 2018-2021. [More Information]
  • Islam, M., Topp, L., Conigrave, K., Haber, P., White, A., Day, C. (2013). Sexually transmitted infections, sexual risk behaviours and perceived barriers to safe sex among drug users. Australian and New Zealand Journal of Public Health, 37(4), 311-315. [More Information]
  • Islam, M., Shanahan, M., Topp, L., Conigrave, K., White, A., Day, C. (2013). The cost of providing primary health-care services from a needle and syringe program: A case study. Drug and Alcohol Review, 32(3), 312-319. [More Information]

2012

  • Deacon, R., Topp, L., Wand, H., Day, C., Rodgers, C., Haber, P., van Beek, I., Maher, L. (2012). Correlates of Susceptibility to Hepatitis B among People Who Inject Drugs in Sydney, Australia. Journal of Urban Health, 89(5), 769-778. [More Information]
  • Alavi, M., Grebely, J., Matthews, G., Petoumenos, K., Yeung, B., Day, C., Lloyd, A., van Beek, I., Kaldor, J., Hellard, M., Haber, P., et al (2012). Effect of pegylated interferon alfa-2a treatment on mental health during recent hepatitis C virus infection. Journal of Gastroenterology and Hepatology, 27(5), 957-965. [More Information]
  • Day, C., Demirkol, A., Tynan, M., Curry, K., Hines, S., Lintzeris, N., Haber, P. (2012). Individual versus team-based case-management for clients of opioid treatment services: An initial evaluation of what clients prefer. Drug and Alcohol Review, 31(4), 499-506. [More Information]
  • Islam, M., Topp, L., Conigrave, K., White, A., Reid, S., Grummett, S., Haber, P., Day, C. (2012). Linkage into specialist hepatitis C treatment services of injecting drug users attending a needle syringe program-based primary healthcare centre. Journal of Substance Abuse Treatment, 43(4), 440-445. [More Information]
  • Mofizul Islam, M., Topp, L., Day, C., Dawson, A., Conigrave, K. (2012). Primary healthcare outlets that target injecting drug users: Opportunity to make services accessible and acceptable to the target group. International Journal of Drug Policy, 23(2), 109-110. [More Information]
  • Mofizul Islam, M., Topp, L., Day, C., Dawson, A., Conigrave, K. (2012). The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: A narrative synthesis of literature. International Journal of Drug Policy, 23(2), 94-102. [More Information]
  • Islam, M., Topp, L., Conigrave, K., van Beek, I., Maher, L., White, A., Rodgers, C., Day, C. (2012). The reliability of sensitive information provided by injecting drug users in a clinical setting: Clinician-administered versus audio computer-assisted self-interviewing (ACASI). AIDS Care - Psychological and Socio-Medical Aspects of AIDS/Hiv, 24(12), 1496-1503. [More Information]

2011

  • Mofizul Islam, M., Grummett, S., White, A., Reid, S., Day, C., Haber, P. (2011). A primary healthcare clinic in a needle syringe program may contribute to HIV prevention by early detection of incident HIV in an injecting drug user. Australian and New Zealand Journal of Public Health, 35(3), 294-295. [More Information]
  • Day, C., Topp, L. (2011). Commentary on Turner et al. (2011): Significant global scale-up of harm reduction interventions and pragmatic research approaches needed to prevent hepatitis C transmission. Addiction, 106(11), 1989-1990. [More Information]
  • Day, C., Mofizul Islam, M., White, A., Reid, S., Hayes, S., Haber, P. (2011). Development of a nurse-led primary healthcare service for injecting drug users in inner-city Sydney. Australian Journal of Primary Health, 17(1), 10-15. [More Information]
  • Topp, L., Day, C., Iversen, J., Wand, H., Maher, L. (2011). Fifteen years of HIV surveillance among people who inject drugs: the Australian Needle and Syringe Program Survey 1995–2009. AIDS, 25(6), 835-842. [More Information]
  • Chaar, B., Hanrahan, J., Day, C. (2011). Provision of Opioid Substitution Therapy Services in Australian Pharmacies. The Australasian Medical Journal, 4(4), 210-216. [More Information]

2010

  • Sanson-Fisher, R., Brand, M., Shakeshaft, A., Haber, P., Day, C., Conigrave, K., Mattick, R., Lintzeris, N., Teesson, M. (2010). Forming a national multicentre collaboration to conduct clinical trials: increasing high-quality research in the drug and alcohol field. Drug and Alcohol Review, 29(5), 469-474. [More Information]
  • Mofizul Islam, M., Day, C., Conigrave, K. (2010). Harm reduction healthcare: From an alternative to the mainstream platform? International Journal of Drug Policy, 21(2), 131-133. [More Information]
  • Day, C., White, B., Dore, G., van Beek, I., Rodgers, C., Cunningham, P., Wodak, A., Maher, L. (2010). Hepatitis B virus among injecting drug users in Sydney, Australia: prevalence, vaccination and knowledge of status. Drug and Alcohol Dependence, 108(40210 (1-2)), 134-137. [More Information]
  • Dunn, M., Day, C., Bruno, R., Degenhardt, L., Campbell, G. (2010). Sexual and injecting risk behaviours among regular ecstasy users. Addictive Behaviors, 35(2), 157-160. [More Information]
  • Ramasamy, P., Lintzeris, N., Sutton, Y., Taylor, H., Day, C., Haber, P. (2010). The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinic. Addiction, 105(2), 329-334. [More Information]

2009

  • Doab, A., Topp, L., Day, C., Dore, G., Maher, L. (2009). Clinical trial literacy among injecting drug users in Sydney, Australia: A pilot study. Contemporary Clinical Trials, 30(5), 431-435. [More Information]
  • Day, C., Haber, P. (2009). Managing drug dependence in people with hepatitis C. In G. Dore, M. Temple-Smith, A. Lloyd (Eds.), Hepatitis C: An Expanding Perspective, (pp. 288-307). East Hawthorn, Victoria: IP Communications.
  • Topp, L., Day, C., Dore, G., Maher, L. (2009). Poor criterion validity of self-reported hepatitis B infection and vaccination status among injecting drug users: A review. Drug and Alcohol Review, 28(6), 669-675. [More Information]
  • Coupland, H., Day, C., Levy, M., Maher, L. (2009). Promoting equitable access to hepatitis C treatment for Indo-Chinese injecting drug users. Health Promotion Journal of Australia, 20(3), 234-240. [More Information]

2008

  • White, B., Day, C., Thein, H., Doab, A., Bates, A., Holden, J., van Beek, I., Maher, L. (2008). Acceptability of hepatitis C virus testing methods among injecting drug users. Drug and Alcohol Review, 27, 666-670. [More Information]
  • Conroy, E., Kimber, J., Dolan, K., Day, C. (2008). An examination of the quality of life among rural and outer metropolitan injecting drug users in NSW, Australia. Addiction Research and Theory, 16(6), 607-617. [More Information]
  • Conroy, E., Kimber, J., Dolan, K., Day, C. (2008). An examination of the quality of life among rural and outer metropolitan injecting drug users in NSW, Australia. Addiction Research and Theory, 16, 607-617. [More Information]
  • Day, C., Topp, L., Iversen, J., Maher, L., Australian NSPs, C. (2008). Blood-borne virus prevalence and risk among steroid injectors: Results from the Australian Needle and Syringe Program Survey. Drug and Alcohol Review, 27(5), 559-561. [More Information]
  • Day, C., White, B., Thein, H., Doab, A., Dore, G., Bates, A., Holden, J., Maher, L. (2008). Experience of hepatitis C testing among injecting drug users in Sydney, Australia. AIDS Care - Psychological and Socio-Medical Aspects of AIDS/Hiv, 20(1), 116-123. [More Information]
  • O'Brien, S., Day, C., Black, E., Dolan, K. (2008). Injecting drug users' understanding of hepatitis C. Addictive Behaviors, 33(12), 1602-1605. [More Information]
  • Topp, L., Iversen, J., Wand, H., Day, C., Kaldor, J., Maher, L. (2008). Representativeness of Injecting Drug Users Who Participate in HIV Surveillance: Results From Australia’s Needle and Syringe Program Survey. JAIDS-Journal of Acquired Immune Deficiency Syndromes, 47(5), 632-638. [More Information]

2007

  • White, B., Day, C., Maher, L. (2007). Self reported risk behaviour among injecting drug users: Self versus assisted questionnaire completion. AIDS Care - Psychological and Socio-Medical Aspects of AIDS/Hiv, 19(3), 441-447. [More Information]

2006

  • Day, C., Degenhardt, L., Hall, W. (2006). Changes in the initiation of heroin use after a reduction in heroin supply. Drug and Alcohol Review, 25(4), 307-313. [More Information]
  • Day, C., Dolan, K. (2006). Correlates of hepatitis C testing among heroin injectors in Sydney. Health Promotion Journal of Australia, 17(1), 70-72. [More Information]
  • Day, C., Degenhardt, L., Hall, W. (2006). Documenting the heroin shortage in New South Wales. Drug and Alcohol Review, 25(4), 297-305. [More Information]
  • Degenhardt, L., Day, C., Conroy, E., Gilmour, S. (2006). Examining Links Between Cocaine Use and Street-Based Sex Work in New South Wales, Australia. Journal of Sex Research, 43(2), 107-114. [More Information]
  • Gilmour, S., Koch, I., Degenhardt, L., Day, C. (2006). Identification and quantification of change in Australian illicit drug markets. BMC Public Health, 6, 200-1-200-10. [More Information]
  • Conroy, E., Degenhardt, L., Day, C. (2006). Impact of Drug Market Changes on Substance-Using Pregnant Women in Three Key Sydney Drug Markets. Women and Health: the multidisciplinary journal of women's health issues, 44(4), 93-105. [More Information]
  • Day, C., Nassirimanesh, B., Shakeshaft, A., Dolan, K. (2006). Patterns of drug use among a sample of drug users and injecting drug users attending a General Practice in Iran. Harm Reduction Journal, 3, 2-1-2-5. [More Information]
  • Day, C., Conroy, E., Lowe, J., Page, J., Dolan, K. (2006). Patterns of drug use and associated harms among rural injecting drug users: Comparisons with metropolitan injecting drug users. Australian Journal of Rural Health, 14(3), 120-125. [More Information]
  • White, B., Day, C., Degenhardt, L., Kinner, S., Fry, C., Bruno, R., Johnston, J. (2006). Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia. Drug and Alcohol Dependence, 83(3), 210-217. [More Information]
  • Degenhardt, L., Day, C., Gilmour, S., Hall, W. (2006). The "lessons" of the Australian "heroin shortage". Substance Abuse Treatment, Prevention, and Policy, 1, 11-1-11-7. [More Information]
  • Gilmour, S., Degenhardt, L., Hall, W., Day, C. (2006). Using intervention time series analyses to assess the effects of imperfectly identifiable natural events: a general method and example. BMC Medical Research Methodology, 6, 16-1-16-9. [More Information]

2005

  • Degenhardt, L., Day, C., Conroy, E., Gilmour, S., Hall, W. (2005). Age differentials in the impacts of reduced heroin: Effects of a "heroin shortage" in NSW, Australia. Drug and Alcohol Dependence, 79(3), 397-404. [More Information]
  • Degenhardt, L., Day, C., Dietze, P., Pointer, S., Conroy, E., Collins, L., Hall, W. (2005). Effects of a sustained heroin shortage in three Australian States. Addiction, 100(7), 908-920. [More Information]
  • Day, C., Ross, J., Dietze, P., Dolan, K. (2005). Initiation to heroin injecting among heroin users in Sydney, Australia: cross sectional survey. Harm Reduction Journal, 2, 2-1-2-7. [More Information]
  • Degenhardt, L., Hall, W., Day, C., Dietze, P., Collins, L., Pointer, S. (2005). Mapping the Consequences of an Unanticipated Drug Supply Change of Uncertain Origins: Response to the Commentaries. Addiction, 100(7), 930-932. [More Information]
  • Degenhardt, L., Day, C., Gilmour, S., Hall, W. (2005). Patterns of illicit drug use in NSW, Australia following a reduction in heroin supply. International Journal of Drug Policy, 16(5), 300-307. [More Information]
  • Shakeshaft, A., Nassirimanesh, B., Day, C., Dolan, K. (2005). Perceptions of substance use, treatment options and training needs among Iranian primary care physicians. International Journal for Equity in Health, 4, 7-1-7-6. [More Information]
  • Gibson, A., Degenhardt, L., Day, C., McKetin, R. (2005). Recent trends in heroin supply to markets in Australia, the United States and Western Europe. International Journal of Drug Policy, 16(5), 293-299. [More Information]
  • Degenhardt, L., Conroy, E., Day, C., Gilmour, S., Hall, W. (2005). The impact of a reduction in drug supply on demand for and compliance with treatment for drug dependence. Drug and Alcohol Dependence, 79(2), 129-135. [More Information]
  • Day, C., Degenhardt, L., Gilmour, S., Hall, W. (2005). The impact of changes to heroin supply on blood-borne virus notifications and injecting related harms in New South Wales, Australia. BMC Public Health, 5, 84-1-84-8. [More Information]
  • Gibson, A., Day, C., Degenhardt, L. (2005). The impact of illicit drug market changes on health agency operations in Sydney, Australia. Journal of Substance Abuse Treatment, 28(1), 35-40. [More Information]
  • Degenhardt, L., Day, C., Hall, W., Conroy, E., Gilmour, S. (2005). Was an increase in cocaine use among injecting drug users in New South Wales, Australia, accompanied by an increase in violent crime? BMC Public Health, 5, 40-1-40-10. [More Information]
  • Southgate, E., Weatherall, A., Day, C., Dolan, K. (2005). What's in a virus? Folk understandings of hepatitis C infection and infectiousness among injecting drug users in Kings Cross, Sydney. International Journal for Equity in Health, 4, 5-1-5-6. [More Information]

2004

  • Day, C., Degenhardt, L., Gilmour, S., Hall, W. (2004). Effects of reduction in heroin supply on injecting drug use: analysis of data from needle and syringe programmes. BMJ: British Medical Journal, 329(7463), 428-429. [More Information]
  • Day, C., Jayasuriya, R., Stone, G. (2004). Hepatitis C-related discriminationin New South Wales. Australian Health Review, 27(2), 57-60.
  • Day, C., Collins, L., Degenhardt, L., Thetford, C., Maher, L. (2004). Reliability of Heroin Users' Reports of Drug Use Behaviour Using a 24-Month Timeline-Follow-Back Technique to Assess the Impact of the Australian Heroin Shortage. Addiction Research and Theory, 12(5), 433-443. [More Information]

2003

  • Lynskey, M., Day, C., Hall, W. (2003). Alcohol and other drug use disorders among older-aged people. Drug and Alcohol Review, 22(2), 125-133.
  • Topp, L., Day, C., Degenhardt, L. (2003). Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia. Drug and Alcohol Dependence, 70, 275-286. [More Information]
  • Day, C., Ross, J., Dolan, K. (2003). Characteristics of Aboriginal Injecting Drug Users in Sydney, Australia: Prison History, Hepatitis C Status and Drug Treatment Experiences. Journal of Ethnicity in Substance Abuse, 2(3), 51-58. [More Information]
  • Topp, L., Degenhardt, L., Day, C., Collins, L. (2003). Contemplating drug monitoring systems in the light of Australia's "heroin shortage" [Editorial]. Drug and Alcohol Review, 22(1), 3-6. [More Information]
  • Day, C., Topp, L., Rouen, D., Darke, S., Hall, W., Dolan, K. (2003). Decreased heroin availability in Sydney in early 2001. Addiction, 98(1), 93-95. [More Information]
  • Day, C., Ross, J., Dolan, K. (2003). Hepatitis C-related discrimination among heroin users in Sydney: drug user or hepatitis C discrimination? Drug and Alcohol Review, 22(3), 317-321. [More Information]
  • Degenhardt, L., Topp, L., Day, C. (2003). Issues surrounding the detection of a reduction in drug supply: the heroin shortage in Australia in 2001. United Nations. Bulletin on Narcotics, 55(1-2), 131-140.
  • Day, C., White, B., Ross, J., Dolan, K. (2003). Poor knowledge and low coverage of hepatitis B vaccination among injecting drug users in Sydney [Letter]. Australian and New Zealand Journal of Public Health, 27(5), 558.
  • Day, C., Topp, L. (2003). Safety in drug and alcohol research [Editorial]. Addiction, 98(12), 1641-1643. [More Information]

To update your profile click here. For support on your academic profile contact .